Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.

Authors: Huang, J-M; Nagatomo, I; Suzuki, E; Mizuno, T; Kumagai, T; Berezov, A; Zhang, H; Karlan, B; Greene, M I; Wang, Q

Published In Oncogene, (2013 Apr 25)

Abstract: The Yes-associated protein (YAP) is a transcriptional factor involved in tissue development and tumorigenesis. Although YAP has been recognized as a key element of the Hippo signaling pathway, the mechanisms that regulate YAP activities remain to be fully characterized. In this study, we demonstrate that the non-receptor type protein tyrosine phosphatase 14 (PTPN14) functions as a negative regulator of YAP. We show that YAP forms a protein complex with PTPN14 through the WW domains of YAP and the PPXY motifs of PTPN14. In addition, PTPN14 inhibits YAP-mediated transcriptional activities. Knockdown of YAP sensitizes cancer cells to various anti-cancer agents, such as cisplatin, the EGFR tyrosine kinase inhibitor erlotinib and the small-molecule antagonist of survivin, S12. YAP-targeted modalities may be used in combination with other cancer drugs to achieve maximal therapeutic effects.

PubMed ID: 22689061 Exiting the NIEHS site

MeSH Terms: Adaptor Proteins, Signal Transducing/chemistry; Adaptor Proteins, Signal Transducing/genetics; Adaptor Proteins, Signal Transducing/metabolism*; Amino Acid Motifs; Animals; Antineoplastic Agents/pharmacology*; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin/pharmacology; Gene Knockdown Techniques; Genes, Reporter; HEK293 Cells; Humans; Inhibitor of Apoptosis Proteins/antagonists & inhibitors*; Inhibitor of Apoptosis Proteins/metabolism; Luciferases, Renilla/biosynthesis; Luciferases, Renilla/genetics; Mice; NIH 3T3 Cells; Peptide Fragments/chemistry; Phosphoproteins/chemistry; Phosphoproteins/genetics; Phosphoproteins/metabolism*; Protein Binding; Protein Interaction Domains and Motifs; Protein Interaction Mapping; Protein Tyrosine Phosphatases, Non-Receptor/chemistry; Protein Tyrosine Phosphatases, Non-Receptor/metabolism*; Quinazolines/pharmacology*; RNA, Small Interfering/genetics; Receptor, Epidermal Growth Factor/antagonists & inhibitors*; Receptor, Epidermal Growth Factor/metabolism; Transcription Factors/metabolism; Transcriptional Activation

to Top